THE USE OF HEAT IN THERAPY
The application of heat in the treatment of disease was first recorded in the ancient civilizations of Egypt, Greece, and Rome from as early as 2000 BC [1].
Fever is one of the body's own defensive and healing forces, created and sustained for the deliberate purpose of restoring health. The high temperature speeds up metabolism, inhibits the growth of the invading virus or bacteria, and literally burns the enemy with heat. Fever is an effective protective and healing measure not only against colds and simple infections, but against such serious diseases as polio and cancer. In biological clinics, overheating therapies or artificially in the treatment of acute infectious diseases, arthritis and rheumatic disease, skin disorders, insomnia, muscular pain and cancer.

I visited the 10 th International Chemistry Conference and Exhibition in Africa , hosted by Garyounis University , Benghazi (Libya) from 18 th to 21 st November 2007. Theme of this conference is“Recent Advances in Chemistry and Their Applications in Progress of African Countries”. The conference will comprise lectures of invited speakers, oral presentations and poster presentations from professionals working in academic institutions, research institutes and industries from different parts of the world. Research papers in different topics of Chemistry were being presented. About one hundred seventy research papers were selected for presentation in different sessions of the conference. Group discussions on the following topics are being held in the conference:
Technical Sessions
• Analytical Chemistry
• Biochemistry
• Environmental Chemistry
• Inorganic Chemistry
• Industrial Chemistry
• Medicinal Chemistry
• Organic Chemistry

These are some guidelines collected from internet resources, Pharmacists are frequently called on to prepare sterile products intended for ophthalmic administration when a suitable sterile ophthalmic product is not available from a licensed manufacturer. These products may be administered topically or by subconjunctival or intraocular (e.g., intravitreal and intracameral) injection and may be in the form of solutions, suspensions, or ointments. he sterility of these products, as well as accuracy in the calculation and preparation of doses, is of great importance. Ocular infections and loss of vision caused by contamination of extemporaneously prepared ophthalmic products have been reported. Drugs administered by subconjunctival or intraocular injection often have narrow therapeutic indices.

Tiny remote-controlled tubes may one day let doctors deliver potent drugs to the exact spots in the body they are most needed.
The nanotubes, which are typically about 100 nanometers long, or one ten-millionth of an inch, are made from a special polymer that conducts electricity.
Here's how it's done:
Drug molecules and fibers of a polymer that breaks down in the body are mixed together. The mixture is placed on the tip of a tiny gold electrode, a type of medical probe that can transmit or receive electrical signals.

Elevated intraocular pressure (IOP) is one of the most important risk factors for the development of glaucoma, which is a progressive optic neuropathy. Lowering IOP is currently the only therapeutic approach

The advent of more efficient methods to synthesize and screen new chemical compounds is increasing the number of chemical leads identified in the drug discovery phase. Compounds with good biological

  This guidance was originally published as a part of a proposed implementation document entitled "U.S. FDA's Proposed Implementation of International Conference on Harmonisation (ICH) Safety

 A new anti-cancer drug delivery system which allows more

On 29 March this year, the US FDA's Office of Cellular, Tissue and Gene Therapies Advisory Committee met to discuss the fate of Dendreon's leading cancer vaccine candidate Provenge (Sipuleucel-T). Provenge represents an extreme of 'personalized medicine'. Dendritic cells, which mop up antigens and present them to other cells of the immune system to stimulate a response, are taken from patients and then sent to one of Dendreon's repositories where they are treated with the prostate-specific antigen prostatic acid phosphatase (PAP), which is found in 95% of prostate cancers.